Abstract
Stem/progenitor cells for cell therapy and regenerative medicine should ideally be available in large numbers, after having been isolated using minimally invasive or non-invasive methodologies. Also, they should exhibit wide differentiation potential into multiple lineages, as well as capability to be used successfully in autologous or allogeneic transplantation, and all this in accordance with the applicable guidelines of good manufacturing practice. Thus, the identification and characterization of alternative sources of mesenchymal stem cells (MSCs) is of great importance. The human uterus emerges as an interesting source of MSCs. Both endometrial MSCs (eMSCs) and human uterine cervical stem cells (hUCESCs) were easily obtained with minimal morbidity. Both eMSCs and hUCESCs show a high proliferation rate, which allows for the harvesting of high amounts of these cells, both for research studies and potential therapeutic uses. It has been demonstrated that eMSCs have wide capability of differentiation into many cellular lineages, as well as potential therapeutic effects in several pathological processes. Similarly, hUCESCs’secretome (conditioned medium) shows potent antiinflammatory, anti-tumor, anti-bacterial and regenerative properties.
Keywords: Conditioned media, exosomes, secretome, stem cells, uterus, eMSCs, hUCESCs.
Current Stem Cell Research & Therapy
Title:Non Pregnant Human Uterus as Source of Mesenchymal Stem Cells
Volume: 13 Issue: 6
Author(s): Noemi Eiro, Maria Fraile, Jose Schneider and Francisco J. Vizoso*
Affiliation:
- Research Unit, Fundacion Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijon,Spain
Keywords: Conditioned media, exosomes, secretome, stem cells, uterus, eMSCs, hUCESCs.
Abstract: Stem/progenitor cells for cell therapy and regenerative medicine should ideally be available in large numbers, after having been isolated using minimally invasive or non-invasive methodologies. Also, they should exhibit wide differentiation potential into multiple lineages, as well as capability to be used successfully in autologous or allogeneic transplantation, and all this in accordance with the applicable guidelines of good manufacturing practice. Thus, the identification and characterization of alternative sources of mesenchymal stem cells (MSCs) is of great importance. The human uterus emerges as an interesting source of MSCs. Both endometrial MSCs (eMSCs) and human uterine cervical stem cells (hUCESCs) were easily obtained with minimal morbidity. Both eMSCs and hUCESCs show a high proliferation rate, which allows for the harvesting of high amounts of these cells, both for research studies and potential therapeutic uses. It has been demonstrated that eMSCs have wide capability of differentiation into many cellular lineages, as well as potential therapeutic effects in several pathological processes. Similarly, hUCESCs’secretome (conditioned medium) shows potent antiinflammatory, anti-tumor, anti-bacterial and regenerative properties.
Export Options
About this article
Cite this article as:
Eiro Noemi , Fraile Maria , Schneider Jose and Vizoso J. Francisco *, Non Pregnant Human Uterus as Source of Mesenchymal Stem Cells, Current Stem Cell Research & Therapy 2018; 13 (6) . https://dx.doi.org/10.2174/1381612824666180426120459
| DOI https://dx.doi.org/10.2174/1381612824666180426120459 |
Print ISSN 1574-888X |
| Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
Call for Papers in Thematic Issues
Molecular Mechanisms and Translational Strategies Targeting the Disease Immune Microenvironment
This thematic issue aims to highlight recent advances in deciphering the molecular mechanisms underlying the disease immune microenvironment, with a particular focus on cancer and chronic inflammatory conditions. It will bring together cutting-edge research in immune regulation, biomarker discovery, epigenetic remodeling, and post-translational modifications that influence disease progression and therapeutic ...read more
Stem Cells and Their Derivatives in Cardiovascular Diseases and Complications
Cardiovascular diseases (CVDs) are a global health burden. Stem cells and their derivatives, such as extracellular vesicles (EVs), offer therapeutic opportunities for CVDs and their complications. This thematic issue of Current Stem Cell Research & Therapy will showcase the latest research on the mechanisms by which stem cells and EVs ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Peptides in Oral Diseases
Current Pharmaceutical Design Anti-Cancer / Anti-Tumor
Current Bioactive Compounds Impact of Curcumin on Microsomal Enzyme Activities: Drug Interaction and Chemopreventive Studies
Current Medicinal Chemistry Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future
Current Pharmaceutical Design Protective Effects of Downregulating Estrogen Receptor Alpha Expression in Cervical Cancer
Anti-Cancer Agents in Medicinal Chemistry Control of Neuropathic Pain by Immune Cells and Opioids
CNS & Neurological Disorders - Drug Targets Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer
Current Cancer Drug Targets Impact of Epigenetic Dietary Components on Cancer through Histone Modifications
Current Medicinal Chemistry Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents
Current Medicinal Chemistry Destabilizing Aneuploidy by Targeting Cell Cycle and Mitotic Checkpoint Proteins in Cancer Cells
Current Drug Targets Antimicrobial and Structural Properties of Metal Ions Complexes with Thiosemicarbazide Motif and Related Heterocyclic Compounds
Current Medicinal Chemistry Tetraspanins - Gateways for Infection
Infectious Disorders - Drug Targets Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent
Current Cancer Drug Targets Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions
Current Topics in Medicinal Chemistry The Role of Chronic Periodontitis in Prevention and Treatment of Head and Neck Cancers
Current Cancer Therapy Reviews The Antitumor Efficiency of Zinc Finger Nuclease Combined with Cisplatin and Trichostatin A in Cervical Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies
Current Medicinal Chemistry Impact of Human Papillomavirus (HPV) Infection on the Treatment Outcome of Concomitant Chemoradiotherapy (CRT) in Cervical Cancer
Current Cancer Therapy Reviews Descending Necrotizing Mediastinitis of Odontogenic Origin
Recent Patents on Anti-Infective Drug Discovery Delivery of Intracellular-Acting Biologics in Pro-Apoptotic Therapies
Current Pharmaceutical Design





